View Older Stories View More Recent Stories

Sep 9, 2015 12:00PM VisionCare Ophthalmic Technologies Expands Executive Team
Aug 26, 2015 11:51AM ThromboGenics Business Update H1 2015
Aug 26, 2015 11:40AM ThromboGenics Business Update H1 2015
Aug 10, 2015 04:00PM Ignyta Announces Second Quarter 2015 Company Highlights and Financial Results
Aug 5, 2015 12:31PM Acucela Hires Dr. Lukas Scheibler as Executive Vice President of Translational Medicine
Aug 5, 2015 08:06AM Ohr Pharmaceutical (OHRP) Appoints New CEO
Aug 5, 2015 08:00AM Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Jul 30, 2015 04:33PM EPGL and Novartis to Enter Discussions
Jul 30, 2015 04:33PM EPGL and Novartis to Enter Discussions
Jul 27, 2015 08:00AM Sierra Monitor Corporation Announces Financial Results for the Second Quarter Ended June 30, 2015
Jul 22, 2015 07:00AM Ignyta Boosts Leadership Capacity with Appointment of Bernard Parker as Chief Commercial Officer
Jul 22, 2015 07:00AM Inotek Pharmaceuticals Appoints Dr. Cadmus Collins Rich as Vice President, Medical Affairs and Clinical Development
Jul 21, 2015 08:15AM Novartis (NVS) Tops Q2 EPS by 3c
Jul 1, 2015 07:13AM Alcon (NVS) Receives CE Mark for AcrySof IQ Aspheric IOL with UltraSert
Jul 1, 2015 07:00AM Innocoll AG Appoints Jose Carmona as Chief Financial Officer
Jun 25, 2015 01:32PM Alcon launches new hydrogen peroxide-based contact lens cleaning & disinfecting solution in the US
Jun 25, 2015 08:00AM Sebacia Announces New Vice President, Engineering and Program Management
Jun 22, 2015 08:40AM Alcon Laboratories Honors KLLM Transport/FFE as Global Partner of the Year
Jun 21, 2015 11:00PM Marshall B. Ketchum University Announces Its 2015 V-Award Honorees for the Fifth Annual MBKU Gala
Jun 16, 2015 06:24AM Alcon (NVS) Receives CE Mark for AcrySof IQ PanOptix Trifocal IOL
May 27, 2015 01:22PM Acelity L.P. Inc. Appoints Two New Members to Its Board of Directors
May 21, 2015 01:33AM ThromboGenics Q1 2015 Business Update
May 19, 2015 09:00AM Fishman Corporation Named 2014 Alcon Supplier of Excellence
May 19, 2015 01:15AM Alcon Study Reveals Nearly Half of Americans Would Avoid Reading Glasses If They Knew It Made Them Look Older
May 13, 2015 03:09AM Fishman Corporation Named 2014 Alcon Supplier of Excellence
May 7, 2015 08:00AM Aerie Pharmaceuticals Elects Richard Croarkin to the Company’s Board of Directors
Apr 23, 2015 01:36AM ThromboGenics Starts Evaluating JETREA(r) for the Treatment of Retinal Vein Occlusion (RVO)
Apr 15, 2015 08:00AM VisionCare Ophthalmic Technologies Names Wolfgang Tolle Chief Executive Officer
Apr 14, 2015 01:37AM ThromboGenics and VIB launch New Oncology Company
Apr 6, 2015 09:06AM Icon Bioscience Reports Successful Outcomes of Phase 3 Study of IBI-10090, a Novel Sustained Release Drug Being Developed to Treat Inflammation Associated with Cataract Surgery
Mar 25, 2015 08:30AM Jeff Evanson Joins Navigant Life Sciences Practice as Managing Director
Mar 24, 2015 09:25AM OASIS Study Clarification with regard to number of ERM Patients recruited
Mar 24, 2015 08:35AM Jeremy Bloom and Rand Fishkin to Keynote iPharma 2015: CBI's 14th Annual Marketing Innovation Summit
Mar 24, 2015 02:33AM ThromboGenics Announces Positive Topline Results from OASIS Study
Mar 17, 2015 05:56PM Cynapsus Therapeutics Reports 2014 Annual Results
Mar 17, 2015 09:00AM Two Global Directors Of Novartis And Alcon File Individual And Collective Gender Discrimination Case
Mar 16, 2015 02:05AM ThromboGenics' JETREA(r) Gains Approval in Brazil
Mar 12, 2015 12:49PM ThromboGenics Full Year 2014 Business Update
Mar 12, 2015 08:30AM Galderma Poised for Growth in the U.S. with Holistic Approach to Skin Health
Mar 5, 2015 09:41AM ThromboGenics Appoints Dr Joseph Markoff as Scientific Advisor
Feb 27, 2015 11:34AM Alcon (NVS) Reports RTH258 Phase 2 Met Primary Endpoint
Jan 15, 2015 05:30PM Akorn Confirms Generic Durezol(R) Patent Challenge
Apr 9, 2014 06:34AM Novartis AG (NVS) Novartis Names New Division Leaders for Sandoz, Alcon
Dec 18, 2013 02:12PM Perrigo (PRGO) Names CEO Papa as Chairman; Announces Director Slate
Nov 22, 2013 07:05AM Novartis (NVS) Announces $5B Buyback Plan; Updates on Long-Term Expectations
Jan 18, 2013 07:43AM Novartis' (NVS) Alcon Receives Positive CHMP Opinion for Jetrea as VMT Treatment
Mar 16, 2012 07:04AM Novartis' (NVS) Unit Gets Exclusive Rights to Ocriplasmin Outside the U.S.
Oct 25, 2011 08:20AM Novartis (NVS) Misses Q3 EPS by 6c, Sales Miss Expectations, Offers Q4 Outlook
Sep 13, 2011 06:44AM Novartis (NVS) Updates on Long-Term Strategy; Comments on Plans for Alcon
Dec 17, 2010 05:43PM Top 10 News Items 12/13-12/17: $858B Tax-Cut Bill Signed; Best Buy Tanks on Concerning Q3 Results; Visa, MasterCard Tumble As Durbin Strikes Back
View More Recent Stories View Older Stories